These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9101574)

  • 21. [Treatment of uveal effusion syndrome after filtering surgery (2 case reports)].
    Pesáková M; Dotrelová D; Kuthan P
    Cesk Slov Oftalmol; 2004 Apr; 60(2):133-8. PubMed ID: 15185452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical results and complications of trabeculectomy with intraoperative application of mitomycin C.
    Matsuda T; Tanihara H; Hangai M; Chihara E; Honda Y
    Jpn J Ophthalmol; 1996; 40(4):526-32. PubMed ID: 9130057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extensive circumferential partial-thickness sclerectomy in eyes with extreme nanophthalmos and spontaneous uveal effusion.
    Mansour A; Stewart MW; Shields CL; Hamam R; Abdul Fattah M; Sheheitli H; Mehanna CJ; Yassine S; Chahine H; Keaik M; Maalouf F; Jaroudi M
    Br J Ophthalmol; 2019 Dec; 103(12):1862-1867. PubMed ID: 30877130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolution of serous retinal detachment following partial sclerectomy with mitomycin C in nanophthalmos.
    Venkatesh P; Majumdar SS; Kakkar A; Singh S; Gogia V; Garg S
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(3):287-9. PubMed ID: 23676234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis.
    Bayer A; Mutlu FM; Sobaci G
    Ophthalmic Surg Lasers; 2002; 33(1):58-61. PubMed ID: 11820665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scleral changes due to mitomycin C after pterygium excision: a report of two cases.
    Saifuddin S; el Zawawi A
    Indian J Ophthalmol; 1995 Jun; 43(2):75-6. PubMed ID: 8818315
    [No Abstract]   [Full Text] [Related]  

  • 27. Measurement of scleral thickness in uveal effusion syndrome.
    Lam A; Sambursky RP; Maguire JI
    Am J Ophthalmol; 2005 Aug; 140(2):329-31. PubMed ID: 16086964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fornix-based trabeculectomy with mitomycin-C.
    Levkovitch-verbin H; Goldenfeld M; Melamed S
    Ophthalmic Surg Lasers; 1997 Oct; 28(10):818-22. PubMed ID: 9336774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cataract surgery in nanophthalmic eyes.
    Brockhurst RJ
    Arch Ophthalmol; 1990 Jul; 108(7):965-7. PubMed ID: 2369356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of glaucoma in young nanophthalmic patients.
    Kocak I; Altintas AG; Yalvac IS; Nurozler A; Kasim R; Duman S
    Int Ophthalmol; 1996-1997; 20(1-3):107-11. PubMed ID: 9112173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APPLICATION OF ADJUNCTIVE TOPICAL MITOMYCIN-C IN SCLEROSTOMY REVISION FOR REFRACTORY IDIOPATHIC UVEAL EFFUSION SYNDROME.
    Zhu I; Haq Z; Ali MH; Chang PY; Zahid S; Mieler WF
    Retin Cases Brief Rep; 2021 Jul; 15(4):339-343. PubMed ID: 30614924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trabeculectomy with mitomycin-C for postkeratoplasty glaucoma: a preliminary study.
    Sharma A; Kumar S; Ram J; Gupta A
    Ophthalmic Surg Lasers; 1997 Nov; 28(11):891-5. PubMed ID: 9387173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and pathologic studies on idiopathic uveal effusion.
    Weng N; Hu W; Sun X; Li L; Fu S
    Zhonghua Yan Ke Za Zhi; 1995 Nov; 31(6):403-11. PubMed ID: 8762565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravitreal triamcinolone and bevacizumab injections for alternative treatment of nanophthalmic uveal effusion syndrome].
    Rüfer F; Varde MA; Roider J
    Klin Monbl Augenheilkd; 2008 Jun; 225(6):594-6. PubMed ID: 18516783
    [No Abstract]   [Full Text] [Related]  

  • 35. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications.
    Russell HC; Chadha V; Lockington D; Kemp EG
    Br J Ophthalmol; 2010 Oct; 94(10):1316-21. PubMed ID: 20530655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periocular allergic contact dermatitis following topical Mitomycin C eye drop application.
    Cumurcu T; Sener S; Cavdar M
    Cutan Ocul Toxicol; 2011 Sep; 30(3):239-40. PubMed ID: 21309691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vortex vein decompression for nanophthalmic uveal effusion.
    Brockhurst RJ
    Arch Ophthalmol; 1980 Nov; 98(11):1987-90. PubMed ID: 7436831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pterygium surgery with mitomycin-C: ten-year results.
    Anduze AL
    Ophthalmic Surg Lasers; 2001; 32(4):341-5. PubMed ID: 11475405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis.
    Bayer A; Mutiu FM; Sobaci G
    Ophthalmic Surg Lasers; 2001; 32(6):490-3. PubMed ID: 11725777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative and postoperative use of mitomycin-C in the treatment of primary pterygium.
    Calişkan S; Orhan M; Irkeç M
    Ophthalmic Surg Lasers; 1996 Jul; 27(7):600-4. PubMed ID: 9240777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.